» Articles » PMID: 7035557

Monoclonal Antibodies to Chlamydia Trachomatis: Antibody Specificities and Antigen Characterization

Overview
Journal J Immunol
Date 1982 Mar 1
PMID 7035557
Citations 101
Authors
Affiliations
Soon will be listed here.
Abstract

Nineteen independent hybrid cell lines that produce monoclonal antibodies to Chlamydia trachomatis surface antigens were prepared by the fusion of mouse myeloma cells with lymphocytes of mice that were immunized with C. trachomatis immunotypes B, C, and L2. Seven serologically distinct reaction patterns were detected by microimmunofluorescence (micro-IF) of elementary body (EB) preparations when culture fluids were tested against a panel of 18 chlamydial serotyping reference strains. These reaction patterns demonstrated genus-, species-, subspecies-, and type-specific distributions. Additionally, these antibodies were tested in parallel against reticulate body (RB) preparations of several chlamydial strains. Monoclonal antibodies that reacted with genus-specific antigens reacted preferentially with RB, whereas antibodies that reacted to species-, subspecies-, or type-specific antigens reacted equivalently to both RB and EB. Physiochemical characterization of antigens recognized by the different monoclonal antibodies was assessed by heat treatment, pronase digestion, periodate oxidation, and immuno-blot techniques. The genus-specific antigen was a heat-stable, pronase-resistant, and relatively periodate-sensitive component of less than 10,000 m.w. The species-, subspecies-, and type-specific antigens were heat stable, pronase sensitive, and periodate resistant. The antibodies that detected species- and subspecies-specific antigens predominantly reacted in immuno-blots with the 40,000 m.w. major outer membrane protein. These monoclonal antibodies now provide a new approach for the precise serologic classification and detection of different C. trachomatis strains.

Citing Articles

RIBAP: a comprehensive bacterial core genome annotation pipeline for pangenome calculation beyond the species level.

Lamkiewicz K, Barf L, Sachse K, Holzer M Genome Biol. 2024; 25(1):170.

PMID: 38951884 PMC: 11218241. DOI: 10.1186/s13059-024-03312-9.


Lysine acetylation of major atis antigens.

Mihailovic J, Inic-Kanada A, Smiljanic K, Stein E, Barisani-Asenbauer T, Cirkovic Velickovic T EuPA Open Proteom. 2018; 10:63-69.

PMID: 29900103 PMC: 5988610. DOI: 10.1016/j.euprot.2016.01.007.


CtGEM typing: Discrimination of Chlamydia trachomatis ocular and urogenital strains and major evolutionary lineages by high resolution melting analysis of two amplified DNA fragments.

Giffard P, Andersson P, Wilson J, Buckley C, Lilliebridge R, Harris T PLoS One. 2018; 13(4):e0195454.

PMID: 29634761 PMC: 5892870. DOI: 10.1371/journal.pone.0195454.


Future of human Chlamydia vaccine: potential of self-adjuvanting biodegradable nanoparticles as safe vaccine delivery vehicles.

Sahu R, Verma R, Dixit S, Igietseme J, Black C, Duncan S Expert Rev Vaccines. 2018; 17(3):217-227.

PMID: 29382248 PMC: 6330895. DOI: 10.1080/14760584.2018.1435279.


Trachoma: Past, present and future.

Mohammadpour M, Abrishami M, Masoumi A, Hashemi H J Curr Ophthalmol. 2016; 28(4):165-169.

PMID: 27830198 PMC: 5093790. DOI: 10.1016/j.joco.2016.08.011.